Systematic literature review to examine the evidence for the effectiveness of interventions that use theories and models of behaviour change: towards the prevention and control of communicable diseases
This systematic literature review assessed the effectiveness of interventions using theories and models of behaviour change to prevent or control communicable diseases relevant to Europe. The review was commissioned by the European Centre for Disease Prevention and Control (ECDC) and conducted by the Institute for Social Marketing of the University of Stirling and the Open University.
There is a substantial body of published work evaluating health interventions using behaviour change theories and models. The review published today provides a unique, systematic overview of the available literature on such interventions and their effectiveness for prevention and control of communicable diseases.
The report presents a detailed mapping of the targets of interventions – diseases and disease groups, populations, types of behaviour for change – and links those to the behaviour change theories and models used. This includes also an overview of the communication channels and activities used by the interventions, as well as the settings in which the interventions took place.
The review also sought to examine the evidence of effectiveness for relevant interventions and programmes based on theories and models of behaviour change. Though it was not possible to identify associations that linked specific theories of behaviour change to intervention outcomes, the report presents a detailed overview of interventions, their target groups, theories and models used and outcomes.
The authors recommend an initiative to collect good-practice case studies for the future that would complement the research evidence and to promote shared learning. The analysis and findings are intended to provide a current status report on the evidence and gaps in order to inform good practice, policy, strategies and future research.
Prevention of hepatitis B and C in the EU/EEA and the UK
24 Nov 2020 - Urgent action is required to improve efforts to prevent hepatitis B and C infections in the EU/EEA and the UK if the region is to meet the 2020 targets for the elimination of viral hepatitis as a serious threat to public health. Significant gaps in the reported data in relation to prevalence and prevention of HBV and HCV in EU/EEA and the UK present a major challenge to monitoring progress towards the targets for elimination of hepatitis.
Updated projections of COVID-19 in the EU/EEA and the UK
23 Nov 2020 - In May 2020, ECDC produced a set of short-term forecasts of the expected number of COVID-19 cases, deaths and hospitalised cases (subdivided into general hospital wards and intensive care units). Updated forecasts were published in September 2020. In this report we present slightly longer-term projections for each country, up until 25 December 2020.
Options for the use of rapid antigen tests for COVID-19 in the EU/EEA and the UK
19 Nov 2020 - This ECDC document is intended to facilitate further discussions between Member States with the aim of reaching agreement on the criteria to be used for the selection of rapid antigen tests, as well as scenarios and settings during which it is appropriate to use rapid antigen tests. This document is also intended to support clinical validations of rapid antigen tests.